Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
43.45
+0.42 (0.98%)
Aug 4, 2025, 4:00 PM - Market closed
Accolade Market Cap
Ionis Pharmaceuticals has a market cap or net worth of $6.93 billion as of August 4, 2025. Its market cap has decreased by -1.07% in one year.
Market Cap
6.93B
Enterprise Value
6.62B
1-Year Change
-1.07%
Ranking
Category
Stock Price
$43.45
Market Cap Chart
Since December 1, 1998, Ionis Pharmaceuticals's market cap has increased from $302.10M to $6.93B, an increase of 2,192.47%. That is a compound annual growth rate of 12.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 6.86B | 24.25% |
Dec 31, 2024 | 5.52B | -23.95% |
Dec 29, 2023 | 7.26B | 35.28% |
Dec 30, 2022 | 5.37B | 24.86% |
Dec 31, 2021 | 4.30B | -45.65% |
Dec 31, 2020 | 7.91B | -6.97% |
Dec 31, 2019 | 8.50B | 14.26% |
Dec 31, 2018 | 7.44B | 18.48% |
Dec 29, 2017 | 6.28B | 8.28% |
Dec 30, 2016 | 5.80B | -22.07% |
Dec 31, 2015 | 7.44B | 1.99% |
Dec 31, 2014 | 7.29B | 57.73% |
Dec 31, 2013 | 4.62B | 337.67% |
Dec 31, 2012 | 1.06B | 46.95% |
Dec 30, 2011 | 719.00M | -28.40% |
Dec 31, 2010 | 1.00B | -8.12% |
Dec 31, 2009 | 1.09B | -20.54% |
Dec 31, 2008 | 1.38B | 0.44% |
Dec 31, 2007 | 1.37B | 62.24% |
Dec 29, 2006 | 844.10M | 123.13% |
Dec 30, 2005 | 378.30M | 11.96% |
Dec 31, 2004 | 337.90M | -6.42% |
Dec 31, 2003 | 361.10M | -0.61% |
Dec 31, 2002 | 363.30M | -65.23% |
Dec 31, 2001 | 1.04B | 152.09% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.37B |
Johnson & Johnson | 402.99B |
AbbVie | 344.84B |
AstraZeneca | 228.08B |
Novartis AG | 224.47B |
Abbott Laboratories | 221.54B |
UnitedHealth Group | 215.69B |
Novo Nordisk | 211.90B |